Background Under conventional cytogenetic (CC) analysis, only 30%-50% of B cell chronic lymphocytic leukemia (B-CLL) cases show clonal aberrations. Using fluore
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective, even the only option to cure patients with certain hematological diseases.HSCT
Background Great advances have been made in the diagnosis, molecular pathogenesis and treatment of acute lymphoblastic leukemia (ALL) in the past decade. Due to